Szabo T, Siccion Z, Izatt S, Vas S I, Bargman J, Oreopoulos D G
Toronto Hospital, Western Division, Ontario, Canada.
Adv Perit Dial. 1999;15:209-12.
We reviewed the course and outcome of all Pseudomonas aeruginosa (PA) exit-site and tunnel infections (ESI/TI) that occurred at our home peritoneal dialysis (PD) unit over a 3-year period (July 1995 to June 1998). We documented PA ESI/TI in 19 out of a total of 467 patients. Of the 19 patients, 12 having local redness and tenderness but no discharge were treated conservatively with increased frequency of dressing with or without hydrogen peroxide locally. Of the 12 cases receiving local care, 7 resolved without recurrence over 14.4 months follow-up, while the remaining 5 developed persistent ESI/TI with discharge and required treatment with antibiotics. Seven more patients who initially presented with purulent discharge also received systemic antibiotics. Only 1 of the 12 patients with PA ESI/TI treated with antibiotics resolved; the remaining 11 patients developed PA peritonitis over a 1-month to 7-month period after the initial PA ESI/TI. In 2 of these 11 patients, simultaneous PD catheter removal and replacement was attempted for the treatment of PA ESI/TI, but these patients also developed PA peritonitis 1-3 weeks after the procedure. Of the 11 patients with PA peritonitis associated with PA ESI/TI, 1 died, 6 were transferred to permanent hemodialysis, and just 4 continued PD after PD catheter replacement. Though not frequent, PA ESI/TI is still a serious complication of home PD at our unit, resulting in ESI/TI-related PA peritonitis and catheter loss in 58% of cases. Local treatment of mild PA ESI/TI (redness and induration) seems to be effective. On the other hand, patients with purulent discharge are likely to develop peritonitis and technique failure despite antibiotic therapy. Early catheter replacement can be considered in these cases.
我们回顾了在我们家庭腹膜透析(PD)单元3年期间(1995年7月至1998年6月)发生的所有铜绿假单胞菌(PA)出口部位和隧道感染(ESI/TI)的病程和结局。我们在总共467例患者中记录到19例PA ESI/TI。在这19例患者中,12例有局部发红和压痛但无渗液,采用增加换药频率并局部使用或不使用过氧化氢的保守治疗。在接受局部治疗的12例病例中,7例在14.4个月的随访中痊愈且无复发,而其余5例出现持续性有渗液的ESI/TI并需要抗生素治疗。另外7例最初表现为脓性渗液的患者也接受了全身抗生素治疗。在接受抗生素治疗的12例PA ESI/TI患者中,只有1例痊愈;其余11例患者在最初的PA ESI/TI后1个月至7个月内发生了PA腹膜炎。在这11例患者中的2例,为治疗PA ESI/TI尝试同时拔除和更换PD导管,但这些患者在手术后1 - 3周也发生了PA腹膜炎。在与PA ESI/TI相关的PA腹膜炎的11例患者中,1例死亡,6例转为永久性血液透析,只有4例在更换PD导管后继续进行腹膜透析。虽然不常见,但PA ESI/TI在我们的单元仍是家庭腹膜透析的严重并发症,在58%的病例中导致与ESI/TI相关的PA腹膜炎和导管丢失。轻度PA ESI/TI(发红和硬结)的局部治疗似乎有效。另一方面,有脓性渗液患者尽管接受抗生素治疗仍可能发生腹膜炎和技术失败。在这些病例中可考虑早期更换导管。